Join us for an insightful webinar where AstraZeneca, Axendia, and Tulip industry leaders will share how life sciences manufacturers can modernize manufacturing operations to deliver more value to their patients by leveraging the CSA (Computer Software Assurance) approach.. Learn how AstraZeneca has successfully transformed its operations by embracing this modern, risk-based methodology to drive innovation and efficiency.
Key Topics:
AstraZeneca’s Digital Transformation Journey: Follow Astrazeneca’s initiatives to bolster innovation, increase productivity, and improve patient outcomes.
The Impact of CSA: Understand how the CSA approach helps manufacturers focus on patient safety and product quality while reducing reliance on non-value-added documentation.
How to Drive Change in Your Organization: Learn from industry experts on how you can fast-track your transformation by leveraging advance technologies and government support.
Why Attend:
Gain valuable insights from industry experts on modernizing validation processes.
Discover strategies for partnering with quality teams to drive innovation while ensuring compliance with the CSA approach.
Explore best practices to accelerate digital transformation and enhance product quality using a risk-based assurance strategy.
Don’t miss this opportunity to learn from industry pioneers and gain actionable insights for your digital transformation journey.
Featuring:
-
Daniel R. Matlis
President & Founder, Axendia, Inc
-
Michelle Vuolo
Head of Quality, Tulip
-
Bob Buhlmann
Head of Quality Digital & Computer Strategy, AstraZeneca